[
  {
    "ts": null,
    "headline": "Why Boston Scientific (BSX) Outpaced the Stock Market Today",
    "summary": "Boston Scientific (BSX) reached $104.33 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close.",
    "url": "https://finnhub.io/api/news?id=9d4d051ea430ad02c2a1557e7a1d416184ae3a27ccb940812cc5495f58c30d8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752530403,
      "headline": "Why Boston Scientific (BSX) Outpaced the Stock Market Today",
      "id": 135937089,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) reached $104.33 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close.",
      "url": "https://finnhub.io/api/news?id=9d4d051ea430ad02c2a1557e7a1d416184ae3a27ccb940812cc5495f58c30d8e"
    }
  },
  {
    "ts": null,
    "headline": "Hinge Health Stock Earns Relative Strength Rating Upgrade",
    "summary": "Hinge Health stock had its Relative Strength (RS) Rating upgraded from 84 to 91 Monday.  See if the Hinge Health stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.",
    "url": "https://finnhub.io/api/news?id=9194fe70a1b1da60eacaa3f70df50c84657a617bf194a8b8ea5b340d4a69aa54",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752512911,
      "headline": "Hinge Health Stock Earns Relative Strength Rating Upgrade",
      "id": 135931997,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Hinge Health stock had its Relative Strength (RS) Rating upgraded from 84 to 91 Monday.  See if the Hinge Health stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.",
      "url": "https://finnhub.io/api/news?id=9194fe70a1b1da60eacaa3f70df50c84657a617bf194a8b8ea5b340d4a69aa54"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=56e53e295aba35e26e8789ffc611514558f60dfb67da54b3f6047b33ff499489",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752510900,
      "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "id": 135950719,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=56e53e295aba35e26e8789ffc611514558f60dfb67da54b3f6047b33ff499489"
    }
  },
  {
    "ts": null,
    "headline": "Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits?",
    "summary": "ELV's second-quarter earnings may face pressure as rising costs and lower Medicaid memberships offset strong revenue gains.",
    "url": "https://finnhub.io/api/news?id=8f9a2b6f68e4ca8199ed370e54999788f3ebb0769f434aa3cd16c28f2d015e4a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752505680,
      "headline": "Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits?",
      "id": 135932259,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ELV's second-quarter earnings may face pressure as rising costs and lower Medicaid memberships offset strong revenue gains.",
      "url": "https://finnhub.io/api/news?id=8f9a2b6f68e4ca8199ed370e54999788f3ebb0769f434aa3cd16c28f2d015e4a"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms",
    "summary": "BIO surges 4% as the Stilla acquisition fuels the launch of four ddPCR systems, expanding to 400K+ assay offerings.",
    "url": "https://finnhub.io/api/news?id=2646c0323791384b0dcf8a876999ff2f84310f4ba33f201fb319c6bf12715fdc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752494820,
      "headline": "Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms",
      "id": 135927723,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BIO surges 4% as the Stilla acquisition fuels the launch of four ddPCR systems, expanding to 400K+ assay offerings.",
      "url": "https://finnhub.io/api/news?id=2646c0323791384b0dcf8a876999ff2f84310f4ba33f201fb319c6bf12715fdc"
    }
  },
  {
    "ts": null,
    "headline": "Prostate Care Market Report 2025-2031 | Medtronic, Johnson & Johnson, Boston Scientific, and Abbott Laboratories Dominate through Product Innovations, Clinical Trials, M&As, and Strategic Partnerships",
    "summary": "Explore the Global Prostate Care Market's growth, projected to reach USD 69.91 billion by 2031, driven by demographic shifts, tech advances, and the rising incidence of prostate conditions. Key players like Medtronic and Johnson & Johnson lead with product innovation. This report analyzes market trends by treatment, disease type, and region.Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The \"Prostate Care Market (2025 Edition): Analysis By Treatment Type (Medications, Surgical Treatments, Minimally I",
    "url": "https://finnhub.io/api/news?id=58160538cd1aad99095fd4e97f4b174bdf26b23f3d1450d82cb248c9e2582a1c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752481020,
      "headline": "Prostate Care Market Report 2025-2031 | Medtronic, Johnson & Johnson, Boston Scientific, and Abbott Laboratories Dominate through Product Innovations, Clinical Trials, M&As, and Strategic Partnerships",
      "id": 135921017,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Explore the Global Prostate Care Market's growth, projected to reach USD 69.91 billion by 2031, driven by demographic shifts, tech advances, and the rising incidence of prostate conditions. Key players like Medtronic and Johnson & Johnson lead with product innovation. This report analyzes market trends by treatment, disease type, and region.Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The \"Prostate Care Market (2025 Edition): Analysis By Treatment Type (Medications, Surgical Treatments, Minimally I",
      "url": "https://finnhub.io/api/news?id=58160538cd1aad99095fd4e97f4b174bdf26b23f3d1450d82cb248c9e2582a1c"
    }
  }
]